F13.959 Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced psychotic disorder, unspecified

Name of the Condition

• Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced psychotic disorder, unspecified

Summary

This condition involves the use of sedative, hypnotic, or anxiolytic substances with an associated psychotic disorder induced by these substances. The pattern of use is not specified further, and the psychotic disorder is directly attributed to the effects of the sedative, hypnotic, or anxiolytic drugs. These substances are commonly prescribed for anxiety, insomnia, or sedation but may lead to psychotic symptoms in some individuals.

Causes

The condition arises from the use of sedative, hypnotic, or anxiolytic drugs, such as benzodiazepines or barbiturates. The psychotic disorder is a direct result of the substance's effects on the central nervous system. Use may be prescribed or non-medical, and the unspecified nature indicates insufficient detail to classify the pattern of use beyond the presence of the induced psychotic disorder.

Risk Factors

• Prolonged or excessive use of these medications
• High dosages or frequent administration
• Personal or family history of substance use disorders
• Underlying mental health conditions (e.g., anxiety, depression)
• Easy access to sedative/hypnotic/anxiolytic drugs
• Recreational or non-medical use

Symptoms

• Use of sedative, hypnotic, or anxiolytic substances
• Presence of psychotic symptoms (e.g., hallucinations, delusions, disorganized thinking)
• Symptoms directly linked to substance use
• No evidence of dependence, withdrawal, or abuse (unless documented)

Diagnosis

Diagnosis is based on clinical evaluation of substance use history and assessment of psychotic symptoms. The unspecified nature indicates that criteria for a more specific pattern of use (e.g., abuse, dependence) are not met or documented. Psychotic symptoms must be directly attributable to the substance's effects.

Treatment Options

Treatment focuses on managing the psychotic symptoms and addressing substance use. Options may include discontinuing or reducing the sedative/hypnotic/anxiolytic use, using antipsychotic medications, and providing supportive care. Underlying mental health conditions should also be addressed.

Prognosis and Follow-Up

Prognosis depends on the severity of symptoms, duration of substance use, and response to treatment. Follow-up care is important to monitor for relapse, manage withdrawal symptoms, and address any ongoing substance use or mental health issues.

Complications

• Worsening of psychotic symptoms
• Increased risk of substance dependence
• Impaired daily functioning
• Potential for self-harm or harm to others
• Interference with treatment for other conditions

Lifestyle & Prevention

• Avoid non-medical use of sedative/hypnotic/anxiolytic drugs
• Follow prescribed dosages and durations
• Seek help for substance use concerns early
• Address underlying mental health conditions
• Educate on risks of prolonged or excessive use

When to Seek Professional Help

Seek immediate medical attention if experiencing severe psychotic symptoms (e.g., hallucinations, delusions) or if substance use is causing significant distress or impairment. Contact a healthcare provider for ongoing substance use or mental health concerns.

Tips for Medical Coders

This code (F13.959) is used when sedative, hypnotic, or anxiolytic use is unspecified and associated with an unspecified sedative, hypnotic, or anxiolytic-induced psychotic disorder. Ensure documentation supports the presence of both the substance use and the induced psychotic disorder without specifying further details about the use pattern or psychotic symptoms. Verify that the psychotic disorder is directly attributed to the substance's effects.